CLEVIPREX clevidipine, 25 mg in 50 mL injectable emulsion, Single Use Vials - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
CLEVIPREX clevidipine, 25 mg in 50 mL injectable emulsion, Single Use Vials
AUST R: 203313
Active ingredients:
clevidipine

Dosage form:
Injection, emulsion

Sponsor:
Chiesi Australia Pty Ltd

Phone:
1800943587

From
10 Mar 2026
to
31 Jul 2026

Shortage status:
Current

Availability:
Limited Availability

Reason:
Transport / Logistic issues / Storage capacity issues

Management action:
An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals